The Therapeutic Goods Administration (TGA) has approved Pfizer Australia and BioNTech SE’s XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY® Omicron XBB.1.5) for individuals aged 5 and over. The decision follows evidence that this vaccine can better protect against symptomatic and severe COVID-19. The vaccine is free and available at pharmacies and general practices across Australia.
Relatient Launches Clinical Request Automation Capability for Dash Voice AI Platform
What You Should Know Relatient has expanded its Dash Voice AI platform with a new clinical request automation capability designed to handle non-scheduling patient phone
